A phase II study of glofitamab plus polatuzumab-R-CHP for patients with high-risk diffuse large B-cell lymphoma
ENROLLING
Trial ID:
NCT05800366 Protocol # :
22-606
Phase
II
Disease Sites
Other Hematopoietic
Non-Hodgkin's Lymphoma
Lymphoid Leukemia
Principal Investigator
Crombie, Jennifer, L.
Site Research Nurses
Brennan, Lisa
Bresnahan, Caitlin
Kilcommons, Marykate
Normilus, Samantha
Patterson, Victoria
Re, Sandra
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #22-606
22-606